<DOC>
	<DOCNO>NCT01718730</DOCNO>
	<brief_summary>The purpose study learn measure brain activity different child adolescent depression different stage treatment . This important may identify biological marker depression could one day use identify depressed child would benefit certain treatment ( medication example ) , monitor well treatment work . Brain activity measure ( know cortical excitability inhibition ) collect Transcranial Magnetic Stimulation ( TMS ) . TMS noninvasive ( surgery implant ) brain stimulation technology make part brain work without put wire chemical body . Measurements take place one 3-hour visit . This study provide form treatment . *There optional portion study use brain scan gather measure brain structure brain chemical . The brain scan call magnetic resonance spectroscopy ( MRI/MRS ) . MRI/MRS use magnetic field study structure brain brain chemical . The PI determine eligibility MRI/MRS portion study .</brief_summary>
	<brief_title>Cortical Excitability Inhibition MDD</brief_title>
	<detailed_description>This study focus understand neurophysiology major depressive disorder ( MDD ) , impact selective serotonin reuptake inhibitor ( SSRIs ) child adolescent . This cross-sectional study utilize single paired-pulse transcranial magnetic stimulation ( TMS ) collect measure glutamatergic cortical excitability ( motor threshold intracortical facilitation ) , GABAergic cortical inhibition ( cortical silent period intracortical inhibition ) motor cortex chilren adolescent various disease state MDD . The optional proton magnetic resonance spectroscopy image scan ( MRS/MRI ) 3 Tesla ( 3T ) examine glutamate concentration motor cortex anterior cingulate cortex . This biomarker study ( MRI/MRS TMS neurophysiology measure ) ; treatment provide form . This study utilize Repetitive Transcranial Magnetic Stimulation ( rTMS ) .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>Adolescents age 13 21 , male female . Subjects MDD ( group 2 , 3 , 4 ) : Must Children 's Depression Rating Scale , Revised ( CDRSR ) score 40 high Must Clinical Global ImpressionSeverity scale ( CGIS ) score 4 high . Group 1 : ( 50 subject ) : Subjects mild ( CDRSR score &lt; 40 ) clinically significant depression . Group 2 : ( 50 subject ) : Subjects moderate severe MDD yet initiate treatment SSRI . Group 3 : ( 50 subject ) : Subjects moderate severe MDD respond treatment SSRI . Group 4 : ( 50 subject ) : Subjects moderate severe MDD respond treatment SSRI . Capable provide informed assent ( consent age 18 ) addition consent parent guardian . Subjects least 1 parent must fluent English . Primary Axis I II disorder MDD . Unprovoked seizure history , seizure disorder , history febrile seizure , family history epilepsy . Any significant finding TMS Adult Safety Screen ( TASS ) contraindication MRI/MRS Subjects judge Principal Investigator imminent risk self harm suicide indicate interview CSSRS . Pregnancy suspect pregnancy female . Metal head ( except mouth* ) , implanted medication pump , cardiac pacemaker . * Subjects brace exclude MRI/MRS portion study Prior brain surgery . Risk increase intracranial pressure brain tumor . Any unstable medical condition .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>TMS</keyword>
	<keyword>Adolescent</keyword>
	<keyword>Child</keyword>
	<keyword>MDD</keyword>
	<keyword>Major depressive disorder</keyword>
	<keyword>Mild MDD</keyword>
	<keyword>Mild depression</keyword>
	<keyword>SSRI</keyword>
	<keyword>Motor cortex</keyword>
	<keyword>Cortical excitability</keyword>
	<keyword>Cortical inhibition</keyword>
	<keyword>Cortical silent period</keyword>
	<keyword>Motor threshold</keyword>
	<keyword>Intracortical facilitation</keyword>
	<keyword>Intracortical inhibition</keyword>
	<keyword>gamma-aminobutyric acid ( GABA )</keyword>
	<keyword>Glutamate</keyword>
	<keyword>N-methyl-D-aspartate ( NMDA )</keyword>
	<keyword>Magnetic resonance spectroscopy</keyword>
	<keyword>MRS</keyword>
</DOC>